ESC 365 - Routinely available inflammation biomarkers as predictors of adverse outcomes following coronary angiography

ESC Professional Premium Access

Routinely available inflammation biomarkers as predictors of adverse outcomes following coronary angiography

Session: Interventional cardiology and biomarkers

Topic: Outcome

Speaker: Doctor E. Steinacher (Vienna, AT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Eva Steinacher

Vienna (Austria)

0 follower

4 more presentations in this session

High-sensitivity c-reactive protein to high-density lipoprotein cholesterol ratio and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention

Speaker: Mr J. Liu (Guangzhou, CN)

Circulating intermediate monocytes increase after elective percutaneous coronary intervention

Speaker: Doctor U. Bhalraam (Norfolk, GB)

Mortality after periprocedural myocardial injury and spontaneous myocardial infarction according to the levels of troponin increase: insights from a large PCI registry

Speaker: Doctor A. Spirito (New York, US)

C-reactive protein levels and coronary in-stent restenosis: A systematic review and meta-analysis

Speaker: Doctor H. Rai (Dublin 7, IE)

Access the full session

Interventional cardiology and biomarkers

Speakers: Doctor E. Steinacher, Mr J. Liu, Doctor U. Bhalraam, Doctor A. Spirito, Doctor H. Rai

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources